Impact of propranolol on preventing renal dysfunction in patients with cirrhosis
Middle East Journal of Digestive Diseases. 2017; 9 (4): 206-211
en Inglés
| IMEMR
| ID: emr-189673
ABSTRACT
Background:
One of the earliest diagnostic signs of hepatorenal syndrome in patients suffering from liver cirrhosis is an increase in the renal vascular resistive index [RI]. In this study, the impact of propranolol on decreasing this index and to postpone the probability of hepatorenal syndrome has been investigated
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Asunto principal:
Propranolol
/
Encuestas y Cuestionarios
/
Ultrasonografía Doppler en Color
/
Cirrosis Hepática
Límite:
Adulto
/
Femenino
/
Humanos
/
Masculino
Idioma:
Inglés
Revista:
Middle East J. Dig. Dis.
Año:
2017
Similares
MEDLINE
...
LILACS
LIS